Schedule 14C is filed by issuers of
securities that are registered under Section 12 of the Securities
Exchange Act of 1934 in connection with a consent
solicitation.
We anticipate that the
amendments will increase the burdens and costs for U.S. companies.
The amendments will increase existing burdens by requiring
companies to make additional disclosures of the following: the
shareholder say-on-pay votes and frequency and the general effect
of such votes, such as whether the vote is non-binding; whether
and, if so, how companies have taken into account the results of
shareholder advisory votes on executive compensation; decision
regarding how frequently it will conduct say-on-pay votes in light
of the results of the shareholder vote on frequency; and
disclosure of golden parachute compensation arrangements in
connection with mergers, acquisitions, tender offers and
going-private transactions. With respect to reporting companies,
portions of the new disclosure will be required in Schedules 14A,
14C, 14D-9, and 13E-3. Additional disclosure will also be required
in Forms 10, 8-K, S-1, S-4, F-4, S-11 and N-2. With respect to
Schedule 14C we estimate an increase of 793 annual burden hours and
an increase of $180,400 in costs.
$100,000
No
No
No
Yes
No
Uncollected
Scott Hodgdon 202
551-3273
No
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.